Significant New Product Approvals
BEST IN INDUSTRY PERFORMANCE!
Eight Significant New Products Approved
- PREVNAR® for Preventing Pneumococcal Diseases (U.S./EU)
- PROTONIX® for Erosive Esophagitis (Oral and I.V.) (U.S.)
- ReFacto® for Hemophilia A (U.S./EU)
- MYLOTARG® for Acute Myelogenous Leukemia (U.S.)
- Meningitec™ for Preventing Meningococcal Diseases (EU)
- SONATA® for Insomnia (U.S./EU)
- RAPAMUNE® for Preventing Kidney Rejection (U.S./EU)
- Totelle™ for Post-menopausal Combined HRT (EU)